The round, led by Almi Invest was partly closed in October 2023 and the company is now very happy to welcome ERM Invest and its clinical development veteran Ola Gudmundsen as a new anchor investor in TrackPaw!
Ola holds a PhD in physiology and is well-known as the founder of the clinical CRO Link Medical AS, where he was the CEO until 2023. Ola has long experience in the drug developmental landscape, primarily in clinical trials and business development.
‘’We are honoured to have received such great support from our investors, who all harbour relevant expertise in the field of life science and technology.It comes to show that our mission of providing solutions for data-driven, efficient and automated monitoring of animal welfare and behavior during pharmaceutical development is shared by many’’ CEO Liza Tchapanova Albrektson says.
The work towards a beta launch of the surveillance system during the fall of 2024 now commences at full speed, along with an further expansion of the IP portfolio.
